-
1
-
-
0037020169
-
Matriptase-2 a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins
-
Velasco, G.; Cal, S.; Quesada, V.; Sánchez, L. M.; López-Qtin, C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J. Biol. Chem., 2002, 277, 37637-37646.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 37637-37646
-
-
Velasco, G.1
Cal, S.2
Quesada, V.3
Sánchez, L.M.4
López-Qtin, C.5
-
2
-
-
0041567036
-
Mouse matriptase-2: Identification characterization and comparative mRNA expression analysis with mouse hepsin in adult embryonic tissue
-
Hooper, J. D.; Campagnolo, L.; Goodarzi, D.; Truong, T. N.; Stuhlmann, H.; Quigley, J. P. Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult embryonic tissue. Biochem. J., 2003, 373, 689-702.
-
(2003)
Biochem. J.
, vol.373
, pp. 689-702
-
-
Hooper, J.D.1
Campagnolo, L.2
Goodarzi, D.3
Truong, T.N.4
Stuhlmann, H.5
Quigley, J.P.6
-
3
-
-
63049086099
-
Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides
-
Beliveau, F.; Desilets, A.; Leduc, R. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J., 2009, 276, 2213-2226.
-
(2009)
FEBS J.
, vol.276
, pp. 2213-2226
-
-
Beliveau, F.1
Desilets, A.2
Leduc, R.3
-
4
-
-
56449096622
-
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin
-
Silvestri, L.; Pagani, A.; Nai, A.; Domenico, I. D.; Kaplan, J.; Camaschella, C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab., 2008, 8, 1-10.
-
(2008)
Cell Metab.
, vol.8
, pp. 1-10
-
-
Silvestri, L.1
Pagani, A.2
Nai, A.3
Domenico, I.D.4
Kaplan, J.5
Camaschella, C.6
-
5
-
-
44449177930
-
The serine protease TMPRSS6 is required to sense iron deficiency
-
Du, X.; She, E.; Gelbart, T.; Truksa, J.; Lee, P.; Xia, Y.; Khovananth, K.; Mudd, S.; Mann, N.; Marie, E.; Moresco, Y.; Beutler, E.; Beutler, B. The serine protease TMPRSS6 is required to sense iron deficiency. Science, 2008, 320, 1088-1092.
-
(2008)
Science
, vol.320
, pp. 1088-1092
-
-
Du, X.1
She, E.2
Gelbart, T.3
Truksa, J.4
Lee, P.5
Xia, Y.6
Khovananth, K.7
Mudd, S.8
Mann, N.9
Marie, E.10
Moresco, Y.11
Beutler, E.12
Beutler, B.13
-
6
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
Nemeth, E.; Tuttle, M. S.; Powelson, J.; Vaughn, M. B.; Donovan, A.; Ward, D. M.; Ganz, T.; Kaplan, J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 2004, 306, 2090-2093.
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.B.4
Donovan, A.5
Ward, D.M.6
Ganz, T.7
Kaplan, J.8
-
7
-
-
54349096688
-
Membrane-bound serine protease matriptase- 2 (Tmprss6) is an essential regulator of iron homeostasis
-
Folgueras, A. R.; Lara, F. M. d.; Pendas, A. M.; Garabaya, C.; Rodriguez, F.; Astudillo, A.; Bernal, T.; Cabanillas, R.; Lopez- Otin, C.; Velasco, G. Membrane-bound serine protease matriptase- 2 (Tmprss6) is an essential regulator of iron homeostasis. Blood, 2008, 112, 2539-2545.
-
(2008)
Blood
, vol.112
, pp. 2539-2545
-
-
Folgueras, A.R.1
Lara, F.M.D.2
Pendas, A.M.3
Garabaya, C.4
Rodriguez, F.5
Astudillo, A.6
Bernal, T.7
Cabanillas, R.8
Lopez- Otin, C.9
Velasco, G.10
-
8
-
-
54349094273
-
A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron
-
Melis, M. A.; Cau, M.; Cangiu, R.; Sole, G.; Barella, S.; Cao, A.; Westerman, M.; Cazzola, M.; Galanello, R. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica, 2008, 93, 1473-1479.
-
(2008)
Haematologica
, vol.93
, pp. 1473-1479
-
-
Melis, M.A.1
Cau, M.2
Cangiu, R.3
Sole, G.4
Barella, S.5
Cao, A.6
Westerman, M.7
Cazzola, M.8
Galanello, R.9
-
9
-
-
67049134745
-
Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associatedwith iron-refractory iron deficiency anemia
-
Silvestri, L.; Guillem, F.; Pagani, A.; Nai, A.; Oudin, C.; Silva, M.; Toutain, F.; Kannengiesser, C.; Beaumont, C.; Camaschella, C.; Grandchamp, B. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associatedwith iron-refractory iron deficiency anemia. Blood, 2009, 113, 5605-5608.
-
(2009)
Blood
, vol.113
, pp. 5605-5608
-
-
Silvestri, L.1
Guillem, F.2
Pagani, A.3
Nai, A.4
Oudin, C.5
Silva, M.6
Toutain, F.7
Kannengiesser, C.8
Beaumont, C.9
Camaschella, C.10
Grandchamp, B.11
-
10
-
-
20244375259
-
DRAGON a bone morphogenetic protein co-receptor
-
Samad, T. A.; Rebbapragada, A.; Bell, E.; Zhang, Y.; Sidis, Y.; Jeong, S. J.; Campagna, J. A.; Perusini, S.; Fabrizio, D. A.; Schneyer, A. L.; Lin, H. Y.; Brivanlou, A. H.; Attisano, L.; Woolf, C. J. DRAGON, a bone morphogenetic protein co-receptor. J. Biol. Chem., 2005, 280, 14122-14129.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 14122-14129
-
-
Samad, T.A.1
Rebbapragada, A.2
Bell, E.3
Zhang, Y.4
Sidis, Y.5
Jeong, S.J.6
Campagna, J.A.7
Perusini, S.8
Fabrizio, D.A.9
Schneyer, A.L.10
Lin, H.Y.11
Brivanlou, A.H.12
Attisano, L.13
Woolf, C.J.14
-
11
-
-
23844456919
-
Repulsive guidance molecule (RGMa) a DRAGON homologue, is a bone morphogenetic protein co-receptor
-
Babitt, B. L.; Zhang, Y.; Samad, T. A.; Xia, Y.; Tang, J.; Campagna, J. A.; Schneyer, A. L.; Woolf, C. J.; Lin, H. Y. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J. Biol. Chem., 2005, 280, 29820-29827.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 29820-29827
-
-
Babitt, B.L.1
Zhang, Y.2
Samad, T.A.3
Xia, Y.4
Tang, J.5
Campagna, J.A.6
Schneyer, A.L.7
Woolf, C.J.8
Lin, H.Y.9
-
12
-
-
33646370235
-
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
-
Babitt, J. L.; Huang, F. W.; Wrighting, D. M.; Xia, Y.; Sidis, Y.; Samad, T. A.; Campagna, J. A.; Chung, R. T.; Schneyer, A. L.; Woolf, C. J.; Andrews, N. C.; Lin, H. Y. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet., 2006, 38, 531-539.
-
(2006)
Nat. Genet.
, vol.38
, pp. 531-539
-
-
Babitt, J.L.1
Huang, F.W.2
Wrighting, D.M.3
Xia, Y.4
Sidis, Y.5
Samad, T.A.6
Campagna, J.A.7
Chung, R.T.8
Schneyer, A.L.9
Woolf, C.J.10
Andrews, N.C.11
Lin, H.Y.12
-
13
-
-
0343012075
-
A novel transmembrane serine protease (tmprss3) overexpressed in pancreatic cancer
-
Wallrapp, C.; Hanel, S.; Muller-Pillasch, F.; Burghardt, B.; Iwamura, T.; Ruthenburger, M.; Lerch, M. M.; Adler, G.; Gress, T. M. A novel transmembrane serine protease (tmprss3) overexpressed in pancreatic cancer. Cancer Res., 2000, 60, 2602-2606.
-
(2000)
Cancer Res.
, vol.60
, pp. 2602-2606
-
-
Wallrapp, C.1
Hanel, S.2
Muller-Pillasch, F.3
Burghardt, B.4
Iwamura, T.5
Ruthenburger, M.6
Lerch, M.M.7
Adler, G.8
Gress, T.M.9
-
14
-
-
21544452009
-
Increased expression of Matriptase is associated with histopathologic grades of cervical neoplasia
-
Lee, J.-W.; Song, S. Y.; Choi, J.-J.; Lee, S.-J.; Kim, B.-G.; Park, C.-S.; Lee, J.-H.; Lin, C.-Y.; Dickson, R. B.; Bae, D.-S. Increased expression of Matriptase is associated with histopathologic grades of cervical neoplasia. Hum. Pathol., 2005, 36, 626-633.
-
(2005)
Hum. Pathol.
, vol.36
, pp. 626-633
-
-
Lee, J.-W.1
Song, S.Y.2
Choi, J.-J.3
Lee, S.-J.4
Kim, B.-G.5
Park, C.-S.6
Lee, J.-H.7
Lin, C.-Y.8
Dickson, R.B.9
Bae, D.-S.10
-
15
-
-
0035423118
-
Expression profiling reveals hepsin overexpression in prostate cancer
-
Magee, J. A.; Araki, T.; Patil, S.; Ehrig, T.; True, L.; Humphrey, P. A.; Catalona, W. J.; Watson, M. A.; Milbrandt, J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res., 2001, 61, 5692-5696.
-
(2001)
Cancer Res.
, vol.61
, pp. 5692-5696
-
-
Magee, J.A.1
Araki, T.2
Patil, S.3
Ehrig, T.4
True, L.5
Humphrey, P.A.6
Catalona, W.J.7
Watson, M.A.8
Milbrandt, J.9
-
16
-
-
2442432225
-
Gene expression profiling identifies matriptase overexpression in malignant mesothelioma.
-
Hoang, C. D.; D'Cunha, J.; Kratzke, M. G.; Casmey, C. E.; Frizelle, S. P.; Maddaus, M. A.; Kratzke, R. A. Gene expression profiling identifies matriptase overexpression in malignant mesothelioma. Chest, 2004, 125, 1843-1852.
-
(2004)
Chest
, vol.125
, pp. 1843-1852
-
-
Hoang, C.D.1
D'Cunha, J.2
Kratzke, M.G.3
Casmey, C.E.4
Frizelle, S.P.5
Maddaus, M.A.6
Kratzke, R.A.7
-
17
-
-
0037688169
-
Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer
-
Netzel-Arnett, S.; Hooper, J. D.; Szabo, R.; Madison, E. L.; Quigley, J. P.; Bugge, T. H.; Antalis, T. M. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev., 2003, 22, 237-258.
-
(2003)
Cancer Metastasis Rev.
, vol.22
, pp. 237-258
-
-
Netzel-Arnett, S.1
Hooper, J.D.2
Szabo, R.3
Madison, E.L.4
Quigley, J.P.5
Bugge, T.H.6
Antalis, T.M.7
-
18
-
-
0035147418
-
Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck
-
Lang, J. C.; Schuller, D. E. Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. Br. J. Cancer, 2001, 84, 237-243.
-
(2001)
Br. J. Cancer
, vol.84
, pp. 237-243
-
-
Lang, J.C.1
Schuller, D.E.2
-
19
-
-
13844320530
-
The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma
-
Mori, Y.; Kono, K.; Matsumoto, Y.; Fujii, H.; Yamane, T.; Mitsumata, M.; Chen, W. T. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma. Oncology, 2004, 67, 411-419.
-
(2004)
Oncology
, vol.67
, pp. 411-419
-
-
Mori, Y.1
Kono, K.2
Matsumoto, Y.3
Fujii, H.4
Yamane, T.5
Mitsumata, M.6
Chen, W.T.7
-
20
-
-
4544224142
-
Gene expression profiles in primary ovarian serous papillary tumours and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
-
Santin, A. D.; Zhan, F.; Bellone, S.; Palmieri, M.; cane, S.; Bignotti, E.; Anfossi, S.; Gokden, M.; Dunn, D.; Roman, J. J.; O'Brien, T. J.; Tian, E.; Cannon, M. J.; Shaughnessy, J.; Pecorelli, S. Gene expression profiles in primary ovarian serous papillary tumours and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int. J. Cancer, 2004, 112, 14-25.
-
(2004)
Int. J. Cancer
, Issue.112
, pp. 14-25
-
-
Santin, A.D.1
Zhan, F.2
Bellone, S.3
Palmieri, M.4
Cane, S.5
Bignotti, E.6
Anfossi, S.7
Gokden, M.8
Dunn, D.9
Roman, J.J.10
O'Brien, T.J.11
Tian, E.12
Cannon, M.J.13
Shaughnessy, J.14
Pecorelli, S.15
-
21
-
-
33846072965
-
Matriptase and its putative role in cancer
-
Uhland, K. Matriptase and its putative role in cancer. Cell. Mol. Life Sci., 2006, 63, 2968-2978.
-
(2006)
Cell. Mol. Life Sci.
, vol.63
, pp. 2968-2978
-
-
Uhland, K.1
-
22
-
-
33644822482
-
In vitro inhibition of Matriptase prevents invasive growth of cell lines of prostate and colon carcinomas
-
Förbs, D.; Thiel, S.; Stella, M. C.; Stürzebecher, A.; Schweinitz, A.; Steinmetzer, T.; Stürzebecher, J.; Uhland, K. In vitro inhibition of Matriptase prevents invasive growth of cell lines of prostate and colon carcinomas. Int. J. Oncol., 2005, 27, 1061-1070.
-
(2005)
Int. J. Oncol.
, vol.27
, pp. 1061-1070
-
-
Förbs, D.1
Thiel, S.2
Stella, M.C.3
Stürzebecher, A.4
Schweinitz, A.5
Steinmetzer, T.6
Stürzebecher, J.7
Uhland, K.8
-
23
-
-
33846076709
-
Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo
-
Sanders, A. J.; Parr, C.; Davies, G.; Martin, T. A.; Lane, J.; Mason, M. D.; Jiang, W. G. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. J. Exp. Ther. Oncol., 2006, 6, 39-48.
-
(2006)
J. Exp. Ther. Oncol.
, vol.6
, pp. 39-48
-
-
Sanders, A.J.1
Parr, C.2
Davies, G.3
Martin, T.A.4
Lane, J.5
Mason, M.D.6
Jiang, W.G.7
-
24
-
-
5344230112
-
CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts
-
Galkin, A. V.; Mullen, L.; Fox, W. D.; Brown, J.; Duncan, D.; Moreno, O.; Madison, E. L.; Agus, D. B. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate, 2004, 61, 228-235.
-
(2004)
Prostate
, vol.61
, pp. 228-235
-
-
Galkin, A.V.1
Mullen, L.2
Fox, W.D.3
Brown, J.4
Duncan, D.5
Moreno, O.6
Madison, E.L.7
Agus, D.B.8
-
25
-
-
0032545728
-
Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas
-
Allione, F.; Eisinger, F.; Parc, P.; Noguchi, T.; Sobol, H.; Birnbaum, D. Loss of heterozygosity at loci from chromosome arm 22q in human sporadic breast carcinomas. Int. J. Cancer, 1998, 75, 181-186.
-
(1998)
Int. J. Cancer
, vol.75
, pp. 181-186
-
-
Allione, F.1
Eisinger, F.2
Parc, P.3
Noguchi, T.4
Sobol, H.5
Birnbaum, D.6
-
26
-
-
0031938046
-
Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer
-
DOI 10.1002/(SICI)1098-2264(199802)21:2<108::AID-GCC5>3.0.CO;2-4
-
Iida, A.; Kurose, K.; Isobe, R.; Akiyama, F.; Sakamoto, G.; Yoshimoto, M.; Kasumi, F.; Nakamura, Y.; Emi, M. Mapping of a new target region of allelic loss to a 2-cm interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer, 1998, 21, 108-112. (Pubitemid 28081236)
-
(1998)
Genes Chromosomes and Cancer
, vol.21
, Issue.2
, pp. 108-112
-
-
Iida, A.1
Kurose, K.2
Isobe, R.3
Akiyama, F.4
Sakamoto, G.5
Yoshimoto, M.6
Kasumi, F.7
Nakamura, Y.8
Emi, M.9
-
27
-
-
0034214364
-
A region of deletion on chromosoem 22q13 is common to human breast and colorectal Cancers
-
Castells, A.; Gusella, J. F.; Ramesh, V.; Rustgi, A. K. A region of deletion on chromosoem 22q13 is common to human breast and colorectal Cancers. Cancer Res., 2000, 60, 2836-2839.
-
(2000)
Cancer Res.
, vol.60
, pp. 2836-2839
-
-
Castells, A.1
Gusella, J.F.2
Ramesh, V.3
Rustgi, A.K.4
-
28
-
-
0034901808
-
Allelic losses of locia at 3p25.1, 8p22, 13q12, 17p13.3, and 22q 13 correlate with postoperative recurrence in breast cancer
-
Hirano, A.; Emi, M.; Tsuneizumi, M.; Utada, Y.; Yoshimoto, M.; Kasumi, F.; Akiyama, F.; Sakamoto, G.; Haga, S.; Kajiwara, T.; Nakamura, Y. Allelic losses of locia at 3p25.1, 8p22, 13q12, 17p13.3, and 22q 13 correlate with postoperative recurrence in breast cancer. Clin. Cancer Res., 2001, 7, 876-882.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 876-882
-
-
Hirano, A.1
Emi, M.2
Tsuneizumi, M.3
Utada, Y.4
Yoshimoto, M.5
Kasumi, F.6
Akiyama, F.7
Sakamoto, G.8
Haga, S.9
Kajiwara, T.10
Nakamura, Y.11
-
29
-
-
33645053497
-
Refinement of the 22q12-q13 breast cancer-associated region: Evidence of tmprss6 as a candidate gene in an eastern Finnish population
-
Hartikainen, J. M.; Tuhkanen, J.; Kataja, V.; Eskelinen, M.; Uusitupa, M.; Kosma, V.-M.; Mannermaa, A. Refinement of the 22q12-q13 breast cancer-associated region: evidence of tmprss6 as a candidate gene in an eastern Finnish population. Clin. Cancer Res., 2006, 12, 1454-1462.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1454-1462
-
-
Hartikainen, J.M.1
Tuhkanen, J.2
Kataja, V.3
Eskelinen, M.4
Uusitupa, M.5
Kosma, V.-M.6
Mannermaa, A.7
-
30
-
-
33747594541
-
The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): Serine proteases and SERPINs identified in leydig cells are under gonadotropin regulation
-
Odet, F.; Verot, A.; Magueresse-Battistoni, B. L. The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): Serine proteases and SERPINs identified in leydig cells are under gonadotropin regulation. Endocrinology, 2006, 147, 4374-4383.
-
(2006)
Endocrinology
, vol.147
, pp. 4374-4383
-
-
Odet, F.1
Verot, A.2
Magueresse-Battistoni, B.L.3
-
31
-
-
3242777139
-
Protease degradomics: Mass spectrometry discovery of protease substrates and the CLIP-CHIP a dedicated DNA microarray of all human proteases and inhibitors
-
Overall, C. M.; Tam, E. M.; Kappelhoff, R.; Connor, A.; Ewart, T.; Morrison, C. J.; Puente, X.; Lopez-Otin, C.; Seth, A. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol. Chem., 2004, 385, 493-504.
-
(2004)
Biol. Chem.
, vol.385
, pp. 493-504
-
-
Overall, C.M.1
Tam, E.M.2
Kappelhoff, R.3
Connor, A.4
Ewart, T.5
Morrison, C.J.6
Puente, X.7
Lopez-Otin, C.8
Seth, A.9
-
32
-
-
34250777391
-
Matriptase-2 inhibits breast tumour growth and invasion and correlates with favourable prognosis for breast cancer patients
-
Parr, C.; Sanders, A. J.; Davies, G.; Martin, T.; Lane, J.; Mason, M. D.; Mansel, R. E.; Jiang, W. G. Matriptase-2 inhibits breast tumour growth and invasion and correlates with favourable prognosis for breast cancer patients. Clin. Cancer Res., 2007, 13, 3568-3576.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 3568-3576
-
-
Parr, C.1
Sanders, A.J.2
Davies, G.3
Martin, T.4
Lane, J.5
Mason, M.D.6
Mansel, R.E.7
Jiang, W.G.8
-
33
-
-
48749092358
-
Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localization
-
Sanders, A. J.; Parr, C.; Martin, T. A.; Lane, J.; Mason, M. D.; Jiang, W. G. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. J. Cell. Physiol., 2008, 216, 780-789.
-
(2008)
J. Cell. Physiol.
, vol.216
, pp. 780-789
-
-
Sanders, A.J.1
Parr, C.2
Martin, T.A.3
Lane, J.4
Mason, M.D.5
Jiang, W.G.6
-
34
-
-
0034711244
-
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase an epithelial membrane serine protease
-
Lee, S. L.; Dickson, R. B.; Lin, C. Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem., 2000, 275, 36720-36725.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 36720-36725
-
-
Lee, S.L.1
Dickson, R.B.2
Lin, C.Y.3
-
35
-
-
0034714379
-
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single- chain urokinase-type plasminogen activator as substrates
-
Takeuchi, T.; Harris, J. L.; Huang, W.; Yan, K. W.; Coughlin, S. R.; Craik, C. S. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single- chain urokinase-type plasminogen activator as substrates. J. Biol. Chem., 2000, 275, 26333-26342.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26333-26342
-
-
Takeuchi, T.1
Harris, J.L.2
Huang, W.3
Yan, K.W.4
Coughlin, S.R.5
Craik, C.S.6
-
36
-
-
0035486691
-
Expression of hepatocyte growth factor/ scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells
-
Parr, C.; Jiang, W. G. Expression of hepatocyte growth factor/ scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int. J. Oncol., 2001, 19, 857-863.
-
(2001)
Int. J. Oncol.
, vol.19
, pp. 857-863
-
-
Parr, C.1
Jiang, W.G.2
-
37
-
-
0038505656
-
The HGF/SF antagonist NK4 reverses fibroblast- and HGF- induced prostate tumour growth and angiogenesis in vivo
-
Davies, G.; Mason, M. D.; Martin, T. A.; Parr, C.; Watkins, G.; Lane, J.; Matsumoto, K.; Nakamura, T.; Jiang, W. G. The HGF/SF antagonist NK4 reverses fibroblast- and HGF- induced prostate tumour growth and angiogenesis in vivo. Int. J. Cancer, 2003, 106, 348-354.
-
(2003)
Int. J. Cancer
, vol.106
, pp. 348-354
-
-
Davies, G.1
Mason, M.D.2
Martin, T.A.3
Parr, C.4
Watkins, G.5
Lane, J.6
Matsumoto, K.7
Nakamura, T.8
Jiang, W.G.9
-
38
-
-
0041887145
-
Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist
-
Martin, T. A.; Parr, C.; Davies, G.; Watkins, G.; Lane, J.; Matsumoto, K.; Nakamura, T.; Mansel, R. E.; Jiang, W. G. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis, 2003, 24, 1317-1323.
-
(2003)
Carcinogenesis
, vol.24
, pp. 1317-1323
-
-
Martin, T.A.1
Parr, C.2
Davies, G.3
Watkins, G.4
Lane, J.5
Matsumoto, K.6
Nakamura, T.7
Mansel, R.E.8
Jiang, W.G.9
-
39
-
-
33746355289
-
Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells
-
Parr, C.; Jiang, W. G. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int. J. Cancer, 2006, 119, 1176-1183.
-
(2006)
Int. J. Cancer
, vol.119
, pp. 1176-1183
-
-
Parr, C.1
Jiang, W.G.2
-
40
-
-
67449152947
-
New insights into bone morphogenetic protein signaling: Focus on angiogenesis
-
Moreno-Miralles, I.; Schisler, J. C.; Pattersnon, C. New insights into bone morphogenetic protein signaling: focus on angiogenesis. Curr. Opin. Hematol., 2009, 16, 195-201.
-
(2009)
Curr. Opin. Hematol.
, vol.16
, pp. 195-201
-
-
Moreno-Miralles, I.1
Schisler, J.C.2
Pattersnon, C.3
-
41
-
-
77950850954
-
When BMP signalling goes wrong: The intracellular and molecular mechanisms of BMP signalling in cancer
-
Bokobza, S. M.; Ye, L.; Jiang, W. G. When BMP signalling goes wrong: The intracellular and molecular mechanisms of BMP signalling in cancer. Curr. Signal Transduct. Ther., 2009, 4, 174-195.
-
(2009)
Curr. Signal Transduct. Ther.
, vol.4
, pp. 174-195
-
-
Bokobza, S.M.1
Ye, L.2
Jiang, W.G.3
-
42
-
-
35648995949
-
Cancer metastasis facilitated by developmental pathways: Sonic hedgehog notch and bone morphogenic proteins
-
Bailey, J. M.; Singh, P. K.; Hollingsworth, M. A.. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, notch and bone morphogenic proteins. J. Cell. Biol., 2007, 102, 829-839.
-
(2007)
J. Cell. Biol.
, vol.102
, pp. 829-839
-
-
Bailey, J.M.1
Singh, P.K.2
Hollingsworth, M.A.3
|